Adell Harriman & Carpenter Inc. Sells 926 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Adell Harriman & Carpenter Inc. decreased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 8.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,041 shares of the financial services provider’s stock after selling 926 shares during the quarter. Adell Harriman & Carpenter Inc.’s holdings in iShares Biotechnology ETF were worth $1,364,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Jacobi Capital Management LLC increased its position in iShares Biotechnology ETF by 3.7% during the 3rd quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock valued at $310,000 after purchasing an additional 91 shares during the period. PFG Investments LLC grew its position in shares of iShares Biotechnology ETF by 4.8% in the 3rd quarter. PFG Investments LLC now owns 2,013 shares of the financial services provider’s stock worth $246,000 after buying an additional 93 shares during the last quarter. Huntington National Bank grew its position in shares of iShares Biotechnology ETF by 7.4% in the 3rd quarter. Huntington National Bank now owns 1,450 shares of the financial services provider’s stock worth $177,000 after buying an additional 100 shares during the last quarter. HB Wealth Management LLC grew its position in shares of iShares Biotechnology ETF by 5.9% in the 4th quarter. HB Wealth Management LLC now owns 1,892 shares of the financial services provider’s stock worth $257,000 after buying an additional 105 shares during the last quarter. Finally, Peterson Wealth Management grew its position in shares of iShares Biotechnology ETF by 2.9% in the 3rd quarter. Peterson Wealth Management now owns 3,743 shares of the financial services provider’s stock worth $458,000 after buying an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.6 %

Shares of iShares Biotechnology ETF stock traded down $0.72 on Tuesday, reaching $127.65. The stock had a trading volume of 227,261 shares, compared to its average volume of 1,776,277. The company has a 50 day moving average price of $134.12 and a 200 day moving average price of $129.88. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.